(Q44422818)

2 December 2017

The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

heterocyclic bridged bicyclo compounds

1 December 2022

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1811993

1 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

1 December 2022

author name string

K. Rasmussen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1811993

1 December 2022

M. E. Stockton

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1811993

1 December 2022

J. F. Czachura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1811993

1 December 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

2 December 2017

19 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1811993

full work available at URL

1 December 2022

https://api.elsevier.com/content/article/PII:001429999190781K?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

https://api.elsevier.com/content/article/PII:001429999190781K?httpAccept=text/plain

1 December 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

European Journal of Pharmacology

1 December 2022

published in

1 reference

2 December 2017

205

1 reference

2 December 2017

113-116

1 reference

2 December 2017

1

1 reference

Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons

2 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons.

1 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain

1 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

Effect of 5-HT3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat

1 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study.

1 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons

1 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

Ondansetron in treatment of schizophrenia

1 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

Differential Effects of Classical and Atypical Antipsychotic Drugs on A9 and A10 Dopamine Neurons

1 December 2022

10

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90781-K

1 December 2022

Identifiers

1 reference

2 December 2017

1 reference